ENIGMA MedMatch PGx

MedMatch PGx is a clinically advanced pharmacogenomics (PGx) test designed to guide personalised medication management. By analysing variants in key genes involved in drug metabolism, transport, and response—such as CYP2D6, CYP2C19, CYP3A4, VKORC1, SLCO1B1, and more—this test provides actionable insights into drug efficacy and risk of adverse effects.
This test empowers physicians and pharmacists to:
Avoid trial-and-error prescribing
Reduce adverse drug reactions
Optimize medication selection and dosing
Tailor treatments in psychiatry, cardiology, oncology, pain management, and more
Applications:
Patients with multiple medications (polypharmacy)
History of poor drug response or side effects
Mental health, cardiovascular, and chronic condition management
Report includes:
Personalized drug-gene interaction analysis
Evidence-based clinical guidelines (e.g., CPIC, FDA, PharmGKB)
Suggested alternatives where applicable